OUR DEUFOL IMPACT: Transform.
Support.
Change Lives.

Our Mission: Global Impact through Expertise

At DEUFOL, we see ourselves not just as a company, but as a driving force that creates a positive impact worldwide through our specialized services. From ensuring critical medical equipment to supporting large-scale global projects – our actions make a difference.

Discover our stories that showcase how we change lives and transform industries through our expertise in the supply chain.

Life-Saving Mission: Our Commitment to the Mobile Children's Heart Clinic

As part of our commitment to social responsibility, DEUFOL supports the mobile children’s heart clinic MOHKI, which enabled life-saving procedures for around 30 children in March 2024. Our contribution lies in the logistical support of this remarkable project, ensuring that the necessary medical equipment reaches remote locations on time and safely.

This support allows MOHKI to provide effective medical aid where it is urgently needed. For DEUFOL, this is an opportunity to use our capabilities meaningfully and make a real difference in the lives of others. It is an honor for us to be part of such a project that brings not only health but also new hope.

DEUFOL Supports Global Access to Clean Drinking Water

Water is an essential need, yet clean drinking water remains inaccessible to two billion people worldwide. At DEUFOL, we are committed to alleviating this global challenge. We support machine and plant manufacturers in deploying their technologies where they are most needed.

By providing specialized packaging and logistics services, we help accelerate the installation of modern bottling plants. These efforts enable the increased production of clean drinking water in underserved regions, thereby improving the quality of life for numerous people.

Essential Medical Technology, Securely Packaged by DEUFOL

Medical innovations are crucial for improving healthcare worldwide. DEUFOL plays an important role in the supply chain that delivers life-saving medical devices to places where they are urgently needed. Our expertise in packaging and logistics supports technology companies in transporting their advanced equipment safely and efficiently.

By specializing in the needs of the life sciences industry, DEUFOL ensures that sensitive medical equipment is delivered in compliance with all regulatory requirements. This helps to expand the boundaries of medical care and provide patients worldwide with access to advanced treatments.

Shape the Future with DEUFOL

At DEUFOL, we believe that our employees are the key to our success and our global impact. Are you ready to work on exciting projects that truly make a difference?

Discover diverse career opportunities in a company that drives innovation and sustainable development. Become part of a team that pushes boundaries every day.

Earnings situation in (€ thousand)

1. Hy 2024 2. Hy 2024 1. Hy 2025 2. Hy 2025 1. Hy 2026
Total turnover 154.684 154.459 154.933 156.339 158.911
EBITDA 16.976 17.853 17.738 19.972 17.836
EBIT 6.142 6.891 5.841 6.614 3.486
EBT 3.274 4.105 2.747 3.207 491
Results for the period 2.257 2.151 1.492 1.690 -619
Earnings per share (€) 0,2271) 0,233 0,158 0,168 -0,082

1) Adjustment of earnings per share for the first half of 2024 in accordance with IAS 33 (due to the reverse split); see the 2024 Annual Report.

The key figures included in the report are rounded for commercial purposes. In individual cases, rounding may mean that the values in the report do not add up exactly to the specified total and that the percentages do not correspond exactly to the values shown.

Earnings situation in (€ thousand)

2021 2022 2023 2024 2025
Total turnover 243.049 271.580 294.004 309.142 311.272
EBITDA 27.475 34.033 46.116 34.829 37.710
EBIT 6.340 13.223 16.642 13.032 12.454
EBT 2.906 10.414 11.341 7.379 5.954
Results for the period 1.933 7.009 7.196 4.408 3.182
Earnings per share (€) 0,030 0,151 0,1531) 0,460 0,326

1) Without retroactive adjustment of earnings per share for the year 2023. For adjusted figures in accordance with IAS 33, please refer to the 2024 Annual Report.

The key figures included in the report are rounded for commercial purposes. In individual cases, rounding may mean that the values in the report do not add up exactly to the specified total and that the percentages do not correspond exactly to the values shown.